NICOLE BLAAUW: Open Payments
NPI 1205811767 · MARQUETTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 27 payments from 7 companies in 2025. Trend: 2023 $502 · 2024 $550 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $263 |
| GENZYME CORPORATION | 6 | $139 |
| Janssen Biotech, Inc. | 2 | $110 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $14 |
| Ardelyx, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, RINVOQ, ULTOMIRIS, REZDIFFRA, IBSRELA, ENTYVIO.
Industry payments across MI — which companies pay providers there.
